PCG Molecular Diagnostic Panels and Testing
Comprehensive Testing and Greater Diagnostics
PCG Molecular offers advanced diagnostic testing for Physicians, Clinicians, Health Care Facilities, and
Point of Care options for patients. Our goal is to provide practitioners with pliable business models, affordable tests for their patients, and easy to understand results and post-treatment recommendations. We are a preventive care diagnostic company driven to change the approach to health, from reactive care to proactive care. We are vested in the research and development of genetic, molecular screenings that detect health threats early, are non-invasive, and easy to administer to the patient.
Infectious Disease, Cancer, and Gastrointestinal pathogen
Identification
Infectious disease
click on icons to learn more
Cancer
Gastrointestinal
Cysto One PAP 1.0 - Urinary & Infectious Disease Panel
The Cysto One PAP™ is a molecular test to screen and diagnose low and high grade urinary bladder malignancies as well as urinary tract infections and sexually transmitted diseases.
MOP ID 1.0 - Infectious Disease Panel
The MOP ID ™ is a qualitative in vitro test for the detection of HPV, CT/NG, HSV1/2, Candida, Trichomonas and a quantitative test for HCV, HIV and HBV in specimens from the oral cavity.
Bella One PAP 1.0 - Infectious Disease Panel
The Bella One PAP is the first FDA-approved test to screen not only for 14 high-risk strains of HPV, but also for other sexually transmitted infections that pose a threat to women’s health.
The PCG Molecular® Respiratory 2.1 (RP2.1) Panel
Anal One PAP 1.0 - Cancer Test
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized PCG Molecular RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.
Anal One PAP 1.0 - Cancer Test
The Anal One PAP™ not only shows whether you have anal cancer, but also if your in a higher risk category to contract it. It’s an innovative genetic test that screens for anal cancer and its risk factors in three ways.
The PCG Molecular® FilmArray® Gastrointestinal Panel
The PCG Molecular GI Panel tests stool specimens for common pathogens associated with gastroenteritis. Quickly identifying the correct pathogen can ensure appropriate treatment, improve patient management, and help detect infectious gastroenteritis which can lead to severe illness or death.
